Thomas M. Richards, MS
Articles
July 19th 2013
Change in Claims-Based Diabetes Medications Is a Diabetes Improvement Indicator
Hsien-Yen Chang, PhD Thomas M. Richards, MS Jeanne M. Clark, MD, MPH Jonathan P. Weiner, DrPH Jodi B. Segal, MD, MPH
Without clinical information, a decrease in use of medications can serve as a proxy for clinical improvement.
April 23rd 2012
Predicting Costs With Diabetes Complications Severity Index in Claims Data
Hsien-Yen Chang, PhD Jonathan P. Weiner, DrPH Thomas M. Richards, MS Sara N. Bleich, PhD Jodi B. Segal, MD, MPH
The Diabetes Complications Severity Index without laboratory test results is a good measure of diabetes severity, given its ability to explain costs.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: September 19th 2024 | Updated: November 21st 2024
Institute for Value-Based Medicine®: Speakers Use AML Studies to Illustrate Effects of Disparities, Neighborhood Stress on Outcomes
